(NASDAQ: PAHC) Phibro Animal Health's forecast annual revenue growth rate of 10.4% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 3.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Phibro Animal Health's revenue in 2025 is $1,190,682,000.On average, 3 Wall Street analysts forecast PAHC's revenue for 2026 to be $57,191,461,678, with the lowest PAHC revenue forecast at $53,446,399,501, and the highest PAHC revenue forecast at $59,923,264,723.
In 2027, PAHC is forecast to generate $58,826,992,761 in revenue, with the lowest revenue forecast at $55,236,363,630 and the highest revenue forecast at $61,514,208,837.